Latest Period
n/a
Security Snapshot
GENMAB A/S - Common Stock Institutional Ownership
CUSIP: K3967W102
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 64,085,788
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- K3967W102 - GENMAB A/S - Common Stock is tracked under CUSIP K3967W102.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
- Reported value moved from $4,477,269 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP K3967W102?
CUSIP K3967W102 identifies K3967W102 - GENMAB A/S - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP K3967W102:
Significant Owners of GENMAB A/S - Common Stock based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORBIS INVESTMENT MANAGEMENT LTD | 6.6% | +13% | 4,229,662 | +13% | ORBIS INVESTMENT MANAGEMENT LTD | 31 Dec 2025 | ||
| BlackRock, Inc. | 5.6% | 3,707,346 | BlackRock, Inc. | 31 Mar 2025 |
Institutional Holders of GENMAB A/S - Common Stock across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$4,477,269 | 0 | |
| 2025 Q2 | 216,712 | $4,477,269 | +$4,477,269 | $20.66 | 1 |
| 2024 Q4 | 0 | $0 | -$208,601 | 0 | |
| 2024 Q3 | 862 | $208,601 | -$3,947,931 | $242.00 | 1 |
| 2024 Q2 | 17,176 | $4,306,092 | -$1,113,410 | $250.70 | 1 |
| 2024 Q1 | 20,842 | $6,578,354 | -$821,798 | $1195.30 | 2 |
| 2023 Q4 | 21,876 | $7,698,530 | -$81,393 | $1237.09 | 2 |
| 2023 Q3 | 22,131 | $8,709,733 | -$106,687 | $1431.81 | 2 |
| 2023 Q2 | 22,431 | $9,341,968 | +$1,000,149 | $1479.10 | 2 |
| 2023 Q1 | 22,057 | $8,311,705 | -$149,311 | $376.83 | 1 |
| 2022 Q4 | 22,840 | $10,648,957 | +$1,112,352 | $423.37 | 3 |
| 2022 Q3 | 22,526 | $7,310,000 | -$109,139 | $326.31 | 2 |
| 2022 Q2 | 22,862 | $7,404,000 | -$556,405 | $328.12 | 3 |
| 2022 Q1 | 24,581 | $9,016,000 | -$8,838 | $350.07 | 2 |
| 2021 Q4 | 24,604 | $9,609,000 | +$464,359 | $390.55 | 1 |
| 2021 Q3 | 23,415 | $10,241,000 | -$108,468 | $437.37 | 1 |
| 2021 Q2 | 23,663 | $9,683,000 | +$10,230 | $409.20 | 1 |
| 2021 Q1 | 23,638 | $7,773,000 | +$115,092 | $328.83 | 1 |
| 2020 Q4 | 23,288 | $9,746,000 | -$39,757 | $418.50 | 1 |
| 2020 Q3 | 23,383 | $8,468,000 | -$103,935 | $362.14 | 1 |
| 2020 Q2 | 23,670 | $7,922,000 | -$41,836 | $334.69 | 1 |
| 2020 Q1 | 23,795 | $4,843,000 | -$1,410,464 | $203.53 | 1 |
| 2019 Q4 | 30,725 | $6,783,000 | -$195,377 | $220.76 | 1 |
| 2019 Q3 | 31,610 | $6,417,000 | $203.01 | 1 | |
| 2019 Q2 | 45,609 | $8,387,000 | -$777,667 | $183.89 | 1 |
| 2019 Q1 | 49,838 | $8,650,000 | +$3,507,695 | $173.56 | 1 |
| 2018 Q4 | 29,628 | $4,764,000 | -$5,072,242 | $160.79 | 1 |
| 2018 Q3 | 61,173 | $9,614,000 | +$179,949 | $157.16 | 1 |
| 2018 Q2 | 60,028 | $9,271,000 | -$211,728 | $154.44 | 1 |
| 2018 Q1 | 61,147 | $12,994,000 | +$1,881,121 | $212.34 | 2 |
| 2017 Q4 | 52,295 | $8,673,000 | -$6,738,160 | $165.28 | 2 |
| 2017 Q3 | 87,288 | $19,266,000 | +$5,189,356 | $220.74 | 2 |
| 2017 Q2 | 63,780 | $13,614,000 | +$3,812,688 | $213.45 | 1 |
| 2017 Q1 | 45,918 | $8,834,000 | +$1,484,261 | $192.39 | 1 |
| 2016 Q4 | 38,203 | $6,344,000 | +$573,074 | $166.06 | 1 |
| 2016 Q3 | 34,752 | $5,500,000 | +$1,346,038 | $158.26 | 1 |
| 2016 Q2 | 26,247 | $4,311,000 | +$3,771,447 | $164.25 | 1 |
| 2016 Q1 | 3,285 | $420,000 | +$420,000 | $127.85 | 1 |
| 2015 Q3 | 0 | $0 | -$328,000 | 0 | |
| 2015 Q2 | 3,775 | $328,000 | +$328,000 | $86.89 | 1 |
| 2015 Q1 | 0 | $0 | -$228,000 | 0 | |
| 2014 Q4 | 3,900 | $228,000 | -$7,308 | $58.46 | 1 |
| 2014 Q3 | 4,025 | $171,000 | $42.48 | 1 | |
| 2014 Q2 | 4,025 | $172,000 | -$67,304 | $42.73 | 1 |
| 2014 Q1 | 5,600 | $228,000 | -$97,714 | $40.71 | 1 |